GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: CRL
Hold $55

Charles River Laboratories International, Inc. (NYSE: CRL) reiterated to Hold with price target $55 by Deutsche Bank

Thursday,  Nov 21, 2013  1:25 PM ET by Lynn Gilbert

Deutsche Bank reiterated Charles River Laboratories International, Inc. (NYSE: CRL) to Hold with price target $55. Previously, Deutsche Bank rated Charles
River Laboratories International, Inc. (NYSE: CRL) to Hold with price target $37 on 01/06/2011, when the stock price was valued at $36.29. Since then, Charles River Laboratories International, Inc.'s stock price has gained 42% as of 11/21/2013's recent price of $51.57.

Charles River Laboratories International, Inc. (Charles River) is a global provider of solutions that advance the drug discovery and development process, including research models and associated services, and outsourced preclinical services. The Company operates in two segments: Research Models and Services (RMS) and Preclinical Services (PCS). The Company provides the animal research models required in research and development of drugs, devices and therapies. Charles River?s customer base includes global pharmaceutical companies, a range of biotechnology companies, as well as government agencies, hospitals and academic institutions worldwide. The Company operates approximately 70 facilities in 17 countries worldwide. During the fiscal year ended December 27, 2008 (fiscal 2008), the Company acquired NewLab BioQuality AG and MIR Preclinical Services.

Deutsche Bank is one of the largest European fund managers. DWS was founded in 1956 and is an integral part of the Asset Management division of Deutsche Bank. This division is one of the largest global asset managers.



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy